Monsanto and China: A Match Made in Heaven?
The market opportunity is massive, but questions remain.
With the North American market nearing saturation, Monsanto (MON) has increasingly looked outside the United States for growth. Currently, Brazil and Argentina are the major international markets driving gains in the company's top and bottom lines. In fact, for the first time in its history, the company expects that more than half of gross profit growth in fiscal 2012 will come from international markets. There are still substantial opportunities for sales and margin growth in South American markets (biotech trait penetration and moving farmers up the technology adoption curve). However, we see a massive opportunity in China, since Monsanto currently generates very little of its revenue from the seed market there. While the market is indeed intriguing, many questions remain.
According to data from the U.S. Department of Agriculture, China is the second-largest corn grower in the world, with 2010-11 crop year production of 177 million metric tons. That compares with estimated U.S. production of 316 million metric tons. Monsanto projects that about 70 million acres are planted to hybrid corn each year in China, compared with about 90 million acres in the United States. Corn yields per acre are far lower in China than in the U.S., giving Monsanto the opportunity to entice growers with higher-yielding seed technology; corn yields in China are equivalent to what U.S. farmers experienced in the 1970s. We don't think seed technology is the sole contributor to yield variations between China and the U.S., however. Chinese farmers do not apply as much potash fertilizer per corn acre as their U.S. counterparts, and they often plant corn in more extreme conditions, leaving more-fertile land to crops such as rice and vegetables. As the world's fourth-largest producer of soybeans, China also presents an intriguing opportunity for Monsanto's oil seed business, but we think the firm will initially focus more on corn as it looks to develop the Chinese seed market.
Jeffrey Stafford does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.